SEC Form 4 · accession 0001493152-15-004372
Targeted Medical Pharma, Inc. · TRGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William B Horne
Officer — Chief Financial Officer
Period of report
Sep 11, 2015
Accepted (ET)
Sep 15, 2015 · 3:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420030
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 11, 2015 | A | 65,769 | $0.20 | A | 331,538 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Share issuance was in lieu of salary and issued at a value of $0.20 per share.